Pneumonia empirical therapy of medication.doc

 PAGE \* MERGEFORMAT 7 Pneumonia empirical therapy of medication [Abstract] pneumonia (pneumonia) is a common disease, according to WHO 20 century and early 90’s statistics show that acute respiratory infections (mostly pneumonia) column ranks first in number of infectious diseases, bacterial pathogens causing pneumonia , fungi, chlamydia, mycoplasma, rickettsia, viruses and other microorganisms and less commonly, parasites, flukes, worms and other parasites polyester, including pneumonia and bacterial pneumonia in about half the total, accounted for in our adult pneumonia 80%. It is reported that bacterial pneumonia in the United States the average incidence rate was 3.75%, according to 1994 statistics, the population of bacterial pneumonia common causes of death in the United States accounted for the first six, bacterial pneumonia in China each year about 250 million cases average annual mortality rate of 5%, accounting for a variety of cause of death for 5. nearly 20 years, nosocomial pneumonia become an important, most reported that the incidence rate of 0.5% to 1.0%, included, up to 15% of surgical ICU ~ 20% and the mortality was 50% to 90% and the additional medical expenses each year more than 20 billion dollars. [Keywords]: viral pneumonia; antiviral drugs; Effect (1) in patients with mild to pneumonia: a pathogenic Enterobacteriaceae, Haemophilus influenzae, Streptococcus pneumoniae, MSSA. Antibiotic treatment: the second generation and not with anti-Pseudomonas activity of third-generation cephalosporin (Cephalexin cefotaxime, ceftriaxone, etc.) lactam and -lactamase inhibitors (such as ampicillin and penicillanic maple), fluoroquinolones (ciprofloxacin, ofloxacin) or clindamycin combined macrolide. (2) severe pneumonia: common pathogens are Pseudomonas aeruginosa, MRSA, Acinetobacter, Enterobacter bacteria, anaerobic bacteria. Antibiotic therapy: quinolones or aminoglycosides combined following one of the drugs,